-
Sector Analysis
Lyme Disease (LD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in LD Therapeutics. In 2024 and 2029, Germany is anticipated to have the highest number of incident cases of Lyme disease, representing a large portion of global cases. Currently, the Lyme disease market is saturated with generic drugs, and the penicillin-binding protein (PBP) inhibitor drug class dominates the approved innovator drugs currently available to treat Lyme disease. The Lyme disease pipeline holds 23 molecules, with no asset...
-
Thematic Analysis
FDI Trends in Europe (2025)
Europe experienced a robust growth phase characterized by increased project numbers and capital expenditures from 2023 to 2024, . Europe's share in opened Greenfield Foreign Direct Investment (FDI) projects, dominated by Western Europe, rose to 40% in 2024. Despite visible FDI opportunity, Eurozone GDP growth stunted at 0.9% in 2024, with structural issues like low productivity, rapidly increasing bond yields, and energy costs weighing on industrial competitiveness Despite healthy levels of inward Greenfield FDI recorded in 2024, Europe’s FDI climate is facing the...
-
Sector Analysis
Middle East and Africa (MEA) Home Healthcare Market Summary, Competitive Analysis and Forecast to 2029
Home Healthcare in Middle East & Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Home healthcare refers to medical care provided in a patient's home by a healthcare agency following a doctor's orders or prescriptions. It is care provided to those unable to...
-
Sector Analysis
South America Home Healthcare Market Summary, Competitive Analysis and Forecast to 2029
Home Healthcare in South America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Home healthcare refers to medical care provided in a patient's home by a healthcare agency following a doctor's orders or prescriptions. It is care provided to those unable to receive essential...
-
Sector Analysis
Asia-Pacific (APAC) Home Healthcare Market Summary, Competitive Analysis and Forecast to 2029
Home Healthcare in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Home healthcare refers to medical care provided in a patient's home by a healthcare agency following a doctor's orders or prescriptions. It is care provided to those unable to receive essential medical...
-
Sector Analysis
North America Home Healthcare Market Summary, Competitive Analysis and Forecast to 2029
Home Healthcare in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Home healthcare refers to medical care provided in a patient's home by a healthcare agency following a doctor's orders or prescriptions. It is care provided to those unable to receive essential...
-
Sector Analysis
Europe Home Healthcare Market Summary, Competitive Analysis and Forecast to 2029
Home Healthcare in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Home healthcare refers to medical care provided in a patient's home by a healthcare agency following a doctor's orders or prescriptions. It is care provided to those unable to receive essential medical...
-
Sector Analysis
Home Healthcare Market Summary, Competitive Analysis and Forecast to 2029
Global Home Healthcare industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Home healthcare refers to medical care provided in a patient's home by a healthcare agency following a doctor's orders or prescriptions. It is care provided to those unable to receive essential medical care...
-
Sector Analysis
Cystic Fibrosis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2034
This report deliverables include a PowerPoint report and an Excel-based forecast model and covers the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Canada). The base year of the sales forecast model is 2024, and the forecast period is 2024-2034. This report also includes a number of recent enhancement to the forecast models, specifically the US LoA analysis tab and the interactive patient flow tab. The patient flow tab helps to summarize the number of patients treated...
-
Product Insights
Clinical Trials: Comparator Study Trends
This report provides an overview of active control clinical trials captured in the GlobalData Pharma Intelligence Center. This report provides an overview of active control trials captured in the GlobalData Pharma Intelligence Center until September 1, 2025
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.